2-Arylimino-5,6-dihydro-4H-1,3-thiazines as a new class of cannabinoid receptor agonists. Part 3: Synthesis and activity of isosteric analogs

Bioorg Med Chem Lett. 2008 Dec 15;18(24):6444-7. doi: 10.1016/j.bmcl.2008.10.070. Epub 2008 Oct 19.

Abstract

Structure-activity relationships and efforts to optimize the pharmacokinetic profile of isosteric analogs of 2-arylimino-5,6-dihydro-4H-1,3-thiazines as cannabinoid receptor agonists are described. Among those examined, compound 25 showed potent affinity for cannabinoid receptor 1 (CB1) and receptor 2 (CB2). This compound displayed oral bioavailability and analgesic activity.

MeSH terms

  • Administration, Oral
  • Animals
  • Biological Availability
  • Cannabinoid Receptor Agonists*
  • Cell Line, Tumor
  • Chemistry, Pharmaceutical / methods
  • Drug Design
  • Humans
  • Kinetics
  • Mice
  • Models, Chemical
  • Rats
  • Structure-Activity Relationship
  • Thiazines / chemical synthesis*
  • Thiazines / pharmacokinetics
  • Thiazines / pharmacology*
  • Thiourea / chemistry

Substances

  • Cannabinoid Receptor Agonists
  • Thiazines
  • Thiourea